Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pSG5-ERRbeta2 Citations (2)

Originally described in: ERRbeta Splice Variants Differentially Regulate Cell Cycle Progression.
Heckler MM, Riggins RB Cell Cycle. 2014 Dec 12:0.
PubMed Journal

Articles Citing pSG5-ERRbeta2

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRbeta2) splice variant in breast cancer. Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, Farzanegan A, Roy R, Uren A, Mueller SC, Riggins RB. Oncotarget. 2016 Jul 26;7(30):47201-47220. doi: 10.18632/oncotarget.9719. PubMed
The orphan nuclear receptor estrogen-related receptor beta (ERRbeta) in triple-negative breast cancer. Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Gyorffy B, Tan M, Riggins RB. Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007/s10549-019-05485-5. Epub 2019 Nov 19. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.